BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 263 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23,195,467 | +94.6% | 529,456 | +183.7% | 0.05% | +126.1% |
| Q1 2022 | $11,921,000 | -88.3% | 186,600 | -80.4% | 0.02% | -87.8% |
| Q4 2021 | $101,827,000 | +3553.6% | 950,682 | +3407.4% | 0.19% | +1466.7% |
| Q3 2021 | $2,787,000 | -18.9% | 27,105 | -30.7% | 0.01% | -25.0% |
| Q2 2021 | $3,438,000 | +742.6% | 39,086 | +973.2% | 0.02% | +700.0% |
| Q4 2020 | $408,000 | -98.3% | 3,642 | -98.6% | 0.00% | -98.7% |
| Q3 2020 | $24,186,000 | +1255.7% | 260,902 | +1041.3% | 0.16% | +1191.7% |
| Q2 2020 | $1,784,000 | -85.5% | 22,860 | -89.2% | 0.01% | -90.2% |
| Q1 2020 | $12,340,000 | +2131.5% | 211,006 | +2956.7% | 0.12% | +2975.0% |
| Q4 2019 | $553,000 | +18.7% | 6,903 | -20.1% | 0.00% | -20.0% |
| Q4 2018 | $466,000 | -98.0% | 8,635 | -97.1% | 0.01% | -94.9% |
| Q3 2018 | $23,158,000 | +2624.5% | 296,668 | +879.0% | 0.10% | +1550.0% |
| Q4 2016 | $850,000 | – | 30,302 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |